Chemoinformaics analysis of Nigakihemiacetal C
| Molecular Weight | 380.481 | nRot | 1 |
| Heavy Atom Molecular Weight | 348.225 | nRig | 21 |
| Exact Molecular Weight | 380.22 | nRing | 4 |
| Solubility: LogS | -3.44 | nHRing | 1 |
| Solubility: LogP | 0.927 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 61.2194 |
| nHD | 3 | BPOL | 36.4426 |
| QED | 0.638 |
| Synth | 5.355 |
| Natural Product Likeliness | 3.38 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.017 |
| Pgp-sub | 0.786 |
| HIA | 0.385 |
| CACO-2 | -4.879 |
| MDCK | 0.0000663 |
| BBB | 0.945 |
| PPB | 0.78565 |
| VDSS | 1.485 |
| FU | 0.209172 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.759 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.923 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.077 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.273 |
| CYP3a4-inh | 0.128 |
| CYP3a4-sub | 0.659 |
| CL | 12.37 |
| T12 | 0.188 |
| hERG | 0.029 |
| Ames | 0.014 |
| ROA | 0.258 |
| SkinSen | 0.12 |
| Carcinogencity | 0.03 |
| EI | 0.007 |
| Respiratory | 0.895 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.580569 |